Tag

Podcasts

#136 – AMA #17: Body composition methods tour de force, insulin resistance, and Topo Chico

“Skeletal muscles are the greatest reservoir that you have for glucose disposal.” —Peter Attia

#135 – BJ Miller, M.D.: How understanding death leads to a better life

People die much more miserable than they need to because they haven’t dared to look at this thing called death before it’s too late.” —BJ Miller

#134 – James O’Keefe, M.D.: Preventing cardiovascular disease and the risk of too much exercise

If exercise were a drug, it would be the best drug we have for preventing heart disease . . .. But like with any drug, you’ve got to get the dose right.” — James O’Keefe

#132 – AMA #16: Exploring hot and cold therapy

“All of the work that went into this analysis earlier in the year, it really changed my tune. And I think I’m now at the point where I kind of want to have a sauna, frankly, in the tool kit for longevity.” — Peter Attia

#129 – Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology

Atherogenic lipoproteins are really the issue behind clinical atherosclerotic vascular disease. … The data has just become so overwhelming.” —Tom Dayspring

#128 – Irene Davis, Ph.D.: Evolution of the foot, running injuries, and minimalist shoes

“Rather than have the runners adapt to the running, they took the shoe and adapted it to the runner.” — Irene Davis

#127 – AMA #3 with sleep expert, Matthew Walker, Ph.D.: Fasting, gut health, blue light, caffeine, REM sleep, and more

“Could we think that sleep could now provide a contribution to this Horvath clock of determining your biological age? . . .I think it probably does.” —Matthew Walker, Ph.D.

#126 – Matthew Walker, Ph.D.: Sleep and immune function, chronotypes, hygiene tips, and addressing questions about his book

“It’s not time that heals all wounds. It’s actually time during REM sleep and dreaming that provides this emotional convalescence.” — Matthew Walker, Ph.D.

#125 – John Arnold: The most prolific philanthropist you may not have heard of

“I always recognized the limited social value of trading. I think there is a need for someone to provide risk warehousing and liquidity to markets, but trying to tell the story about how I was adding value or contributing to society was hard. And that always bothered me.” — John Arnold

#124 – AMA #15: Real-world case studies—metabolic dysregulation, low testosterone, menopause, and more

As a follow up to AMA #14 where Peter explained his framework for analyzing labs, this “Ask Me Anything” (AMA)…

Facebook icon Twitter icon Instagram icon Pinterest icon Google+ icon YouTube icon LinkedIn icon Contact icon